News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

AstraZeneca (AZN) Names Tony Zook CEO Of AstraZeneca U.S.

10/19/2005 5:09:20 PM

WILMINGTON, Del., Sept. 15 /PRNewswire-FirstCall/ -- AstraZeneca , one of the world's leading pharmaceutical companies, today announced the appointment of Tony Zook as Executive Vice President for North America, and President and Chief Executive Officer of AstraZeneca US, effective January 1, 2006. Zook will succeed David R. Brennan who was named Chief Executive, AstraZeneca PLC last July. Brennan assumes his role in the new year, upon the retirement of Sir Tom McKillop who led the company following the 1999 merger of Astra AB and Zeneca Group PLC.

(Photo: )

Currently, Zook is the company's Senior Vice President, U.S. Commercial Operations. Previously, he served as Vice President, Sales.

"Tony possesses the leadership skills to grow AstraZeneca's U.S. business in the years to come," said David Brennan. "With over 20 years in the pharmaceutical industry, he is well-suited for this important post at a critical time in our industry."

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. In the United States, AstraZeneca is a $9.6 billion healthcare business with more than 12,000 employees. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

For more information about AstraZeneca, please visit:

Editor's Note: Tony Zook began his sales career in 1983 at Berlex Laboratories, where he held various positions, including district sales manager; marketing director; vice president, commercial operations; and then vice president, sales. He joined Astra USA in 1997 as vice president, marketing and sales, and later assumed the position of vice president, sales in 1998. Prior to assuming his current position, Zook was vice president of sales for AstraZeneca. In this position, he led a 4,000-person sales force.

Zook holds a bachelor's degree in biology from Frostburg University, and an associate's degree in chemical engineering from Penn State University.

Zook is a member of the Board for the Pennsylvania Division of the American Cancer Society and a member of the Executive Council for the National Pharmaceutical Council.

Photo: NewsCom: Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comAstraZeneca

CONTACT: Rachel Bloom-Baglin of AstraZeneca, +1-302-886-7858,

Read at

comments powered by Disqus